This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/524477-france-three-hemophilia-cases-pfizer-vaccine/
The article has changed 3 times. There is an RSS feed of changes available.
Version 1 | Version 2 |
---|---|
French health authorities investigate three cases of rare blood disorder in Pfizer Covid-19 jab recipients | French health authorities investigate three cases of rare blood disorder in Pfizer Covid-19 jab recipients |
(about 2 months later) | |
Three cases of a rare disorder affecting the blood’s ability to clot have been reported among recipients of Pfizer-BioNTech’s Covid-19 vaccine and are being investigated, French health authorities said on Friday. | Three cases of a rare disorder affecting the blood’s ability to clot have been reported among recipients of Pfizer-BioNTech’s Covid-19 vaccine and are being investigated, French health authorities said on Friday. |
The cases of hemophilia were all in people over the age of 75, the ANSM Medicines Agency said. | The cases of hemophilia were all in people over the age of 75, the ANSM Medicines Agency said. |
The cases are France’s first such incidences of hemophilia potentially linked to the Pfizer/BioNTech jab, the regulator said, in its latest pharmacovigilance report on the US-German vaccine for April 30 to May 13. | The cases are France’s first such incidences of hemophilia potentially linked to the Pfizer/BioNTech jab, the regulator said, in its latest pharmacovigilance report on the US-German vaccine for April 30 to May 13. |
“This very rare effect does not call into question the benefit/risk ratio of the vaccine,” the agency added.As of May 13, some 20,964,000 doses of the jab had been administered across the country, according to official data. | “This very rare effect does not call into question the benefit/risk ratio of the vaccine,” the agency added.As of May 13, some 20,964,000 doses of the jab had been administered across the country, according to official data. |
People with hemophilia have insufficient blood-clotting proteins, which combine with blood platelets to clot the blood. Hemophiliacs can, therefore, bleed for longer than usual. | People with hemophilia have insufficient blood-clotting proteins, which combine with blood platelets to clot the blood. Hemophiliacs can, therefore, bleed for longer than usual. |
The condition’s incidence among the general population is extremely rare, with only around 1-1.5 cases per million people annually, French health officials said. | The condition’s incidence among the general population is extremely rare, with only around 1-1.5 cases per million people annually, French health officials said. |
Hemophilia has not been listed as a side effect of the Pfizer vaccine by drug regulators, who have approved the jab. | Hemophilia has not been listed as a side effect of the Pfizer vaccine by drug regulators, who have approved the jab. |
However, the US Food and Drug Administration advises recipients to tell a doctor prior to vaccination if they have a bleeding disorder or are on a blood thinner. | However, the US Food and Drug Administration advises recipients to tell a doctor prior to vaccination if they have a bleeding disorder or are on a blood thinner. |
Rare cases of allergic reactions have occurred in people vaccinated with Pfizer’s vaccine, including a very small number of cases of anaphylaxis, the EU’s drug regulator, the European Medicines Agency, has said. | Rare cases of allergic reactions have occurred in people vaccinated with Pfizer’s vaccine, including a very small number of cases of anaphylaxis, the EU’s drug regulator, the European Medicines Agency, has said. |
Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |